Cartesian Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $6.4M | 237k | 27.01 |